Opinion

Increasing the global supply of essential medical supplies: Time for Europe to step up its global leadership

Europe has already made a significant financial contribution to beating the pandemic, now it has the opportunity and moral responsibility to do more.

By: and Date: July 19, 2021 Topic: European governance

Versions of this piece were originally published in Caixin, Capital, El País, Helsingin Sanomat, Il Sole 24 Ore, Le Grand Continent, Nikkei Veritas and Rzeczpospolita.

caixin logo english

Capital (Bulgaria) logo

El País logo

Rzecszpospolita logo

The COVID-19 pandemic is nowhere near its end at a global level. What is worse, new pandemics are likely to endanger global health in the coming decades, with severe consequences for livelihoods and economic activity. Preventing pandemics is a global public good like climate change mitigation: the world needs to act collectively to avoid future episodes like COVID-19.

It should be a priority to find money to invest in pandemic prevention, preparedness and response, as argued in a report to the G20 finance ministers to which we contributed. This financing would fill major gaps in global health security. In the report, we take a conservative approach and focus exclusively on the funding needs for global public goods needed to prevent pandemics. We estimate that US$15 billion would be needed annually to improve global pandemic surveillance capacities, improve essential elements of national health systems and, very importantly, the supply of medical countermeasures and tools. Spending on pandemic prevention, preparedness and response delivers by far the best return on any public investment. The International Monetary Fund, for example, estimates that a faster global vaccine roll-out could spare the world US$9 trillion in foregone income.

The pandemic has shown how crucial the adequate supply of medical countermeasures is. So far, the global supply of COVID-19 vaccines has been insufficient with billions of people not yet vaccinated. In a business-as-usual scenario, the IMF estimates that vaccine production could reach 6 billion doses by the end of 2021, enabling vaccination of 45% of the world population. This would leave large regions vulnerable and would not prevent the emergence of new variants. In the early phases of the pandemic, personal protective equipment and other medical equipment were also in short supply. This lack of capacity means more severe human suffering, longer-lasting constraints on our social lives and significant losses in terms of global economic activity.

This dangerous situation requires bold global action. Europe can play a major role in providing the world with vaccines now and for future pandemics. European companies have been at the forefront of developing effective COVID-19 vaccines. European Union policymakers have resisted the temptation to using the production primarily for the domestic market. Instead, about half of the vaccines produced in the EU have been exported – contrasting starkly with many other parts of the world, which gave exclusive priority to their people. The EU can thus rightly claim to be a reliable partner to the rest of the world. And the EU should step up even further. It is in Europe’s interest to vaccinate as many as possible as quickly as possible: no one is safe until all are safe.

Three steps are essential. First, many countries still do not have access to sufficient numbers of vaccine doses. And while the EU has been championing multilateral approaches to increase the global supply of vaccines, initiatives such as COVAX have fallen short of what is needed. The June 2021 G7 pledge to increase the supply of vaccines by 1 billion also falls short. Instead of waiting for global consensus, we advise the EU to keep helping the developing world gain access to vaccines. Such support can take the form of donations or grants, or concessional lending to countries for purchase of vaccines. It could also be done through contributions to the COVAX facility. The issue is not only access but also affordability: the EU should help poorer countries to purchase vaccines on terms comparable to domestic purchases when negotiating with European suppliers.

Second, as our G20 report argued, the world needs greater supply capacities for vaccines and other medicines and equipment when there is no global pandemic raging. With potential losses of half a trillion dollars a month, as estimated by the IMF for COVID-19 in the first part of 2021, accelerating vaccine production during pandemics brings huge benefits. But building this capacity in ‘peace-time’ requires a certain degree of subsidisation as private firms by themselves do not have sufficient incentives to maintain redundant production capacities. As the world emerges gradually from the pandemic, and the demand for COVID-19 vaccines declines, the EU would be well advised to continue supporting vaccine supply chains to ensure higher capacities are available. Multi-modal manufacturing capacity (mRNA, protein, and virus-based vaccines and therapeutics) can rapidly ramp up production of pandemic-specific medicines and treatments when needed. Financing is needed for manufacturing of multiple prototype pathogen vaccine/diagnostic/therapeutic candidates before outbreaks. Dual-use purposes should be sought for such capacity, which could contribute to controlling endemic diseases and improving health outcomes in inter-pandemic years. The EU has some of the world’s best research centres in this area and should further build on those by increasing research spending.

Third, production capacities in different regions would make the system more resilient and contribute to more equitable global distribution of scarce supplies. The Franco-German initiative to boost BioNTech vaccine production in South Africa is a positive example of this.

Europe has already made a significant financial contribution to beating the pandemic. It needs to step up further in the short-term by buying and distributing more vaccines. Supporting global efforts, as recommended in our G20 report, also offers opportunities for expansion of an important European industrial sector. It is a moral imperative and a huge opportunity for Europe to step up its efforts to combat pandemics.


Republishing and referencing

Bruegel considers itself a public good and takes no institutional standpoint.

Due to copyright agreements we ask that you kindly email request to republish opinions that have appeared in print to [email protected].

Read about event More on this topic
 

Upcoming Event

Jun
9
13:00

Through crises towards stability: Reflections on 10 years of the ESM with Klaus Regling

How is the European Stability Mechanism responding to crises, and what will the future of the ESM look like?

Speakers: Klaus Regling and Guntram B. Wolff Topic: European governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels
Read article More on this topic More by this author
 

Blog Post

REPowerEU: will EU countries really make it work?

By acting together, the European Union can optimise its response to the energy crisis in all scenarios but each country will have to make concessions.

By: Simone Tagliapietra Topic: Green economy Date: May 18, 2022
Read article More on this topic More by this author
 

Blog Post

European governance

Does the war in Ukraine call for a new Next Generation EU?

The European Union should take significant economic measures in response to the war in Ukraine, but a new Next Generation EU is not needed yet.

By: André Sapir Topic: European governance Date: May 17, 2022
Read article Download PDF
 

Policy Contribution

European governance

Fiscal support and monetary vigilance: economic policy implications of the Russia-Ukraine war for the European Union

Policymakers must think coherently about the joint implications of their actions, from sanctions on Russia to subsidies and transfers to their own citizens, and avoid taking measures that contradict each other. This is what we try to do in this Policy Contribution, focusing on the macroeconomic aspects of relevance for Europe.

By: Olivier Blanchard and Jean Pisani-Ferry Topic: European governance, Macroeconomic policy Date: April 29, 2022
Read article
 

External Publication

European governance

Green public procurement: A neglected tool in the European Green Deal toolbox?

A new EU regulatory action in public procurement could unlock the potential of green public procurement and add an important element to the European Green Deal toolbox.

By: André Sapir, Tom Schraepen and Simone Tagliapietra Topic: European governance, Green economy Date: April 26, 2022
Read article More on this topic
 

External Publication

What drives implementation of the European Union’s policy recommendations to its member countries?

Article published in the Journal of Economic Policy Reform.

By: Konstantinos Efstathiou and Guntram B. Wolff Topic: Macroeconomic policy Date: April 13, 2022
Read article More by this author
 

Blog Post

European governance

Bold European Union action is needed to support Ukrainian refugees

Hosting Ukrainian refugees could cost European Union countries in excess of €40 billion this year. A dedicated EU fund is needed to manage the fiscal burden.

By: Zsolt Darvas Topic: European governance, Global economy and trade Date: April 6, 2022
Read article More on this topic
 

Blog Post

Can Europe manage if Russian oil and coal are cut off?

A stop to Russian oil and coal supplies would push Europe into a short and painful adjustment period. But if managed well, disruptions would remain temporary.

By: Ben McWilliams, Giovanni Sgaravatti, Simone Tagliapietra and Georg Zachmann Topic: Green economy Date: March 17, 2022
Read article More on this topic More by this author
 

Blog Post

European governance

A new Thessaloniki offer: the aspirations of Georgia, Moldova, and Ukraine to join the EU

The European Union should grant candidate status to Georgia, Moldova and Ukraine, as part of a long-term stabilisation strategy.

By: Marek Dabrowski Topic: European governance Date: March 15, 2022
Read article More by this author
 

Blog Post

European governance

How should the EU respond to Georgia, Moldova and Ukraine’s membership aspirations?

European Union membership for Georgia, Moldova and Ukraine is at present unrealistic, but they should be offered more than Association Agreements.

By: André Sapir Topic: European governance, Global economy and trade Date: March 14, 2022
Read article Download PDF More on this topic More by this author
 

Policy Contribution

Is the post-war trading system ending?

This policy contribution assesses how the trading system has changed over the last five years – roughly coinciding with the start of the Trump administration and one year of President Biden – and sets out scenarios for how the situation might evolve.

By: Uri Dadush Topic: Global economy and trade Date: February 21, 2022
Read article More by this author
 

Blog Post

European governance

How has growth changed what countries get from the European recovery fund?

Adjustments to growth forecasts mean some countries will get 10% more than expected and others 20% less in grants from the EU Recovery and Resilience Facility. But the benefits of more quickly rising growth rates dwarf foregone recovery funds.

By: Zsolt Darvas Topic: European governance, Macroeconomic policy Date: February 17, 2022
Load more posts